Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neurogene Inc (NGNE)

Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Neurogene Inc 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 USA

www.neurogene.com Employees: 107 P: 855-508-3568

Sector:

Medical

Description:

Neurogene Inc. is a clinical-stage company which bring life-changing genetic medicines to patients and families affected by rare neurological diseases. Neurogene Inc., formerly known as Neoleukin Therapeutics Inc., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 273,243
Enterprise Value, $K 136,653
Shares Outstanding, K 15,490
Float, K 13,687
% Float 88.36%
Short Interest, K 3,591
Short Float 23.18%
Days to Cover 31.88
Short Volume Ratio 0.84
% of Insider Shareholders 11.64%
% of Institutional Shareholders 52.37%

Financials:

Annual Sales, $ 930 K
Annual Net Income, $ -75,140 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -20,950 K
EBIT, $ -97,310 K
EBITDA, $ -96,480 K

Growth:

1-Year Return 1.91%
3-Year Return 72.81%
5-Year Return -92.67%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 71.47%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.99 on 11/13/25
Next Earnings Date 03/23/26
Earnings Per Share ttm -4.11
EPS Growth vs. Prev Qtr 5.71%
EPS Growth vs. Prev Year 16.81%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 12/19/23

NGNE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -29.84%
Return-on-Assets % -27.55%
Profit Margin % -8,079.57%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.00
Book Value/Share 18.61
Interest Coverage -7,513.00
60-Month Beta 1.59
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar